These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 30518477)
1. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter? Bushinsky DA Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477 [TBL] [Abstract][Full Text] [Related]
2. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease]. Alcázar Arroyo R Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744 [TBL] [Abstract][Full Text] [Related]
3. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis. Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270 [TBL] [Abstract][Full Text] [Related]
4. Metabolic Acidosis of CKD: An Update. Kraut JA; Madias NE Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665 [TBL] [Abstract][Full Text] [Related]
5. NaHCO3 loading causes increased arterial pressure and kidney damage in rats with chronic kidney disease. Mannon EC; Muller PR; Sun J; Bush WB; Coleman A; Ocasio H; Polichnowski AJ; Brands MW; O'Connor PM Clin Sci (Lond); 2024 Feb; 138(4):189-203. PubMed ID: 38300615 [TBL] [Abstract][Full Text] [Related]
6. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study. Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G; J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912 [TBL] [Abstract][Full Text] [Related]
7. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study). Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G Trials; 2013 Jul; 14():196. PubMed ID: 23826760 [TBL] [Abstract][Full Text] [Related]
8. Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease. Goraya N; Simoni J; Sager LN; Mamun A; Madias NE; Wesson DE Am J Physiol Renal Physiol; 2019 Aug; 317(2):F502-F511. PubMed ID: 31215805 [TBL] [Abstract][Full Text] [Related]
9. Clinical evidence that treatment of metabolic acidosis slows the progression of chronic kidney disease. Goraya N; Wesson DE Curr Opin Nephrol Hypertens; 2019 May; 28(3):267-277. PubMed ID: 30681417 [TBL] [Abstract][Full Text] [Related]
10. Effect of Bicarbonate on Net Acid Excretion, Blood Pressure, and Metabolism in Patients With and Without CKD: The Acid Base Compensation in CKD Study. Tyson CC; Luciano A; Modliszewski JL; Corcoran DL; Bain JR; Muehlbauer M; Ilkayeva O; Pourafshar S; Allen J; Bowman C; Gung J; Asplin JR; Pendergast J; Svetkey LP; Lin PH; Scialla JJ Am J Kidney Dis; 2021 Jul; 78(1):38-47. PubMed ID: 33810868 [TBL] [Abstract][Full Text] [Related]
11. Acid retention in chronic kidney disease is inversely related to GFR. Goraya N; Simoni J; Sager LN; Pruszynski J; Wesson DE Am J Physiol Renal Physiol; 2018 May; 314(5):F985-F991. PubMed ID: 29357423 [TBL] [Abstract][Full Text] [Related]
12. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate. Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657 [TBL] [Abstract][Full Text] [Related]
14. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Goraya N; Simoni J; Jo CH; Wesson DE Clin J Am Soc Nephrol; 2013 Mar; 8(3):371-81. PubMed ID: 23393104 [TBL] [Abstract][Full Text] [Related]
15. Does correction of metabolic acidosis slow chronic kidney disease progression? Goraya N; Wesson DE Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803 [TBL] [Abstract][Full Text] [Related]
16. Approach to the Treatment of Chronic Metabolic Acidosis in CKD. Raphael KL Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539 [TBL] [Abstract][Full Text] [Related]
17. Alkali supplementation as a therapeutic in chronic kidney disease: what mediates protection? Mannon EC; O'Connor PM Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1090-F1104. PubMed ID: 33166183 [TBL] [Abstract][Full Text] [Related]
18. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD. Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959 [TBL] [Abstract][Full Text] [Related]
19. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients. Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000 [TBL] [Abstract][Full Text] [Related]
20. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease. Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]